INSPIRIS China PMCF Study

Active, not recruitingOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

July 13, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Aortic Valve Replacement
Interventions
DEVICE

EDWARDS INSPIRIS RESILIA Aortic Valve

Surgical replacement of the aortic valve with the INSPIRIS RESILIA Aortic Valve.

Trial Locations (13)

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

100037

Fuwai Hospital, CAMS & PUMC, Beijing

210012

Nanjing First Hospital, Nanjing

230002

The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei

361008

Xiamen Cardiovascular Hospital Xiamen University, Xiamen

450008

Henan Provincial Chest Hospital, Zhengzhou

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

451460

Fuwai Central China Cardiovascular Hospital, Zhengzhou

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

518038

Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Shenzhen

610072

Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital, Chengdu

650102

Fuwai Yunnan Cardiovascular Hospital, Kunming

710065

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

Sponsors
All Listed Sponsors
collaborator

Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.

INDUSTRY

collaborator

Rundo International Pharmaceutical Research & Development Co.,Ltd.

INDUSTRY

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

lead

Edwards Lifesciences

INDUSTRY